Getryl of Getz Pharma is an oral blood glucose lowering drug of sulfonylurea class. Getryl is chemically glimepiride.
The primary mechanism of action of Getryl appears to be dependent on the stimulating the release of insulin from functioning pancreatic beta cells.
Getryl is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes.
In initiating treatment for non-insulin dependent diabetes, diet and exercise should be emphasized as the primary form of treatment. There is no fixed doses regimen for the management of diabetes with Getryl or anyother hypoglycemic agent.